China SXT Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Two
China SXT Pharmaceuticals, Inc. (SXTC) had Long-Term Debt, Maturity, Year Two of CNY 4.45 million as of 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2026-07-01
- 2026-03-31: Long-Term Debt, Maturity, Year Two 4.45M CNY.
- 2025-09-30: Long-Term Debt, Maturity, Year Two 520.42K CNY.
- 2025-03-31: Long-Term Debt, Maturity, Year Two 698.56K CNY.
- 2024-09-30: Long-Term Debt, Maturity, Year Two 754.00K CNY.
CNY
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2026-03-31 | 4.45M CNY 20-F · filed 2026-07-01 |
| 2025-09-30 | 520.42K CNY 6-K · filed 2025-12-31 |
| 2025-03-31 | 698.56K CNY 20-F · filed 2025-07-31 |
| 2024-09-30 | 754.00K CNY 6-K · filed 2025-03-28 |
| 2024-03-31 | 754.00K CNY 20-F · filed 2024-08-13 |
| 2023-09-30 | 54.00K CNY 6-K · filed 2024-04-05 |
| 2023-03-31 | 54.00K CNY 6-K · filed 2024-04-05 |
USD
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2026-03-31 | $644.39K 20-F · filed 2026-07-01 |
| 2025-09-30 | $73.10K 6-K · filed 2025-12-31 |
| 2025-03-31 | $96.26K 20-F · filed 2025-07-31 |
| 2024-09-30 | $107.44K 6-K · filed 2025-03-28 |
| 2024-03-31 | $104.43K 20-F · filed 2024-08-13 |
| 2023-09-30 | $7.40K 6-K · filed 2024-04-05 |
| 2023-03-31 | $7.86K 6-K · filed 2024-04-05 |